Question 1

How many shares of RETA does HighTower Advisors, LLC own?

Accepted Answer

HighTower Advisors, LLC previously held 0 shares of RETA (REATA PHARMACEUTICALS INC) before exiting the position in 2023-Q3.

Question 2

What is HighTower Advisors, LLC's RETA position worth?

Accepted Answer

HighTower Advisors, LLC's RETA position was last reported at $0 in 2023-Q3 before the exit.

Question 3

Is HighTower Advisors, LLC buying or selling RETA?

Accepted Answer

In 2023-Q3, HighTower Advisors, LLC exited their RETA position entirely (-100.0% change in shares).

Question 4

When did HighTower Advisors, LLC first buy RETA?

Accepted Answer

Based on available 13F filings, HighTower Advisors, LLC first reported a position in RETA in 2020-Q3. They have held the position across 13 quarters.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2023-Q3 Latest	Exited	0	-100.0%	$0	0.0%	—	0
2023-Q2	Decreased	47,574	-2.9%	$4.8M	0.0%	—	0
2023-Q1	Decreased	48,978	-6.5%	$4.5M	0.0%	—	0
2022-Q4	Decreased	52,395	-6.7%	$2M	0.0%	—	0
2022-Q3	Increased	56,150	+0.2%	$1.4M	0.0%	—	25
2022-Q2	Increased	56,015	+2.8%	$1.7M	0.0%	—	26
2022-Q1	Decreased	54,515	-0.6%	$1.8M	0.0%	—	0
2021-Q4	Decreased	54,823	-7.2%	$1.4M	0.0%	—	0
2021-Q3	Decreased	59,090	-14.7%	$5.9M	0.0%	—	0
2021-Q2	Increased	69,260	+17.5%	$9.8M	0.0%	—	32
2021-Q1	Decreased	58,958	-0.1%	$5.9M	0.0%	—	0
2020-Q4	Increased	58,993	+7.6%	$7.3M	0.0%	—	29
2020-Q3	New	54,838	-	$5.3M	0.0%	—	37

RETA13 quarters

RETA
13 quarters